Page results
-
We are asking patients to follow some protocols before they come to UCLH and would appreciate it if you could reiterate this with your patients when you refer them.
-
Diasend is being upgraded to Glooko. The children and young people's diabetes team at UCLH will be upgrading later in the year.
-
UCLH has recruited the first European participant to a trial looking at treating non-hospitalised Covid-19 patients with the drug remdesivir.
-
Information for visitors including visiting times, limit and infection control in place for each ward and location.
-
The X-ray GP Direct Access service for patients has returned to a fully walk-in service, although we will review this decision regularly and let you know if we make changes to the service.
-
All semen analysis referrals should be made via the NHS e-Referral Service (e-RS). We will no longer be able to book semen analysis appointments through direct requests from patients or GP surgeries via email.
-
From 10 September 2025, proxies will be able to see more information in your MyCare account. Proxies are individuals such as parents or carers who have access to your MyCare account.
-
A guide to choosing diabetes technology for UCLH patients
-
A guide for GPs and healthcare professionals on how to refer patients to UCLH.
-
The Getting Ready for Transition (GReaT) Group is an interactive workshop for young people with Type I Diabetes, who will be transitioning to secondary school in September, and their parents.
File results
-
FOI/2022/0150 - Hepatocellular carcinoma drug treatments
-
FOI/2022/0161 - Referral to treatment waiting times
-
FOI/2022/0163 - Ongoing staff absence due to COVID-19
-
FOI/2022/0166 - Routine GP referrals made to Cardiology, Gynaecology and Neurology
-
FOI/2022/0171 - Consultant-led Referral to Treatment (RTT), outpatients and Patient Initiated Follow-up (PIFU)
-
FOI/2022/0186 - Gender neutral toilets at the Trust
-
FOI/2022/0211 - Enteral feeding machine mechanical insufflator
-
FOI/2022/0216 - Inventory management system
-
FOI/2022/0217 - Medications for dermatological conditions
-
FOI/2022/0227 - Number of cancer trackers and cancer MDT co-ordinators at Trust